A new generation of adenosine receptor antagonists: From di- to trisubstituted aminopyrimidines

Bioorganic & Medicinal Chemistry
2008.0

Abstract

New adenosine receptor ligands were designed as hybrid structures between previously synthesized substituted dicyanopyridines and aminopyrimidines, yielding two series of cyano-substituted diphenylaminopyrimidines. We were interested in assessing the effect of this substitution pattern on both affinity and intrinsic activity, as the dicyanopyridines comprised both agonists and inverse agonists, whereas the original aminopyrimidines were exclusively inverse agonists. It was found that the new compounds were generally selective for adenosine A(1) receptors, although affinity for the adenosine A(2A) receptor was also noticed for some of the compounds. In a cAMP second messenger assay the compounds behaved as inverse agonists rather than agonists. Among the more A(1) receptor-selective compounds were 5 (LUF6048), 27 (LUF6040) and 53 (LUF6056) with K(i) values of 8.1, 1.2 and 5.7nM, respectively.

Knowledge Graph

Similar Paper

A new generation of adenosine receptor antagonists: From di- to trisubstituted aminopyrimidines
Bioorganic & Medicinal Chemistry 2008.0
N<sup>6</sup>,5‘-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A<sub>3</sub> Receptor
Journal of Medicinal Chemistry 1999.0
N9-Benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: Synthesis and structure–activity relationships at adenosine A1 and A2A receptors
Bioorganic &amp; Medicinal Chemistry 2007.0
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity
Journal of Medicinal Chemistry 2019.0
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A<sub>1</sub> Antagonists
Journal of Medicinal Chemistry 2022.0
Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity
Journal of Medicinal Chemistry 2016.0
C2,N6-Disubstituted adenosines: synthesis and structure-activity relationships
Journal of Medicinal Chemistry 1989.0
5‘-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives:  Partial Agonists for the Adenosine A<sub>1</sub> and A<sub>3</sub> Receptors
Journal of Medicinal Chemistry 2001.0
Discovery of Potent and Highly Selective A<sub>2B</sub>Adenosine Receptor Antagonist Chemotypes
Journal of Medicinal Chemistry 2016.0
5‘-Substituted Adenosine Analogs as New High-Affinity Partial Agonists for the Adenosine A<sub>1</sub> Receptor
Journal of Medicinal Chemistry 1998.0